Virginia Commonwealth University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Virginia Commonwealth University sits in the top decile of US sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count).
Virginia Commonwealth University: 558 sponsored US clinical trials, 77 recruiting.
Virginia Commonwealth University sponsors 558 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 380 completed. 35 of these trials are in Phase 3-4 (later-stage) and 145 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Virginia Commonwealth University ranks in the top decile of sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
380 of 462 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
558 total, page 7 of 12
Decreasing Antibiotic Use in Infants With Suspected Ventilator-associated Infection
NCT03041207
REducing Anxiety in CHildren Undergoing Procedures
NCT03054077
Interstitial Cystitis: Examination of the Central Autonomic Network
NCT03008382
Ramelteon for Treatment of Insomnia in Cirrhosis
NCT03091738
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
NCT03143855
Effect of Strength and Coordination Training on Biomechanics and Injury in New Runners
NCT03293121
VOR Suppression in Non-Gymnast Adults
NCT03227718
High Dose Vitamin C in Cardiac Surgery Patients
NCT02762331
Alirocumab in Patients With Acute Myocardial Infarction
NCT02938949
Implementing Personal Health Records to Promote Evidence-Based Cancer Screening
NCT02138448
Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease
NCT02730793
TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
NCT02822586
Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy
NCT03059264
24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E
NCT03134183
The Lullaby Project: A Musical Intervention for Pregnant Women
NCT03207919
Improving Symptom Self-management in Adolescents & Young Adults With Cancer
NCT02974569
Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action
NCT02900352
Treatment of Diabetes in Patients With Systolic Heart Failure
NCT02920918
Effects of Cigar Flavors on Measures of Abuse Liability Among Young Adults
NCT02937051
Oral Gut Liver Axis in Cirrhosis
NCT03030820
General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation
NCT02896595
Self-Management of Chronic Depressive Symptoms in Pregnancy
NCT02953990
Using the Peanut Exercise Ball to Reduce Cesarean Section Rates: A Randomized Controlled Trial
NCT02899260
Multimodal Analgesia in Cardiac Surgery (Pilot Study)
NCT02734940
Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer
NCT02795819
SGLT2 Inhibition in Diabetes and Heart Failure
NCT02862067
The Effect of Electronic Cigarette (ECIG) Liquid Vehicles on ECIG Acute Effects
NCT02500615
RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease
NCT02838797
Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy
NCT02676765
Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's
NCT02769000
Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension
NCT03057028
Cold Compress for Pain Associated With Intrauterine Device Insertion
NCT02898831
Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System
NCT02787928
2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer
NCT02624700
The Role of Parents in Adolescent Obesity Treatment
NCT02586090
Low Intensity Weight Loss for Young Adults
NCT02736981
Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis
NCT02593123
MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca
NCT02564549
Understanding the Value of Community Vital Signs in Primary Care
NCT02512835
Postoperative Pain Control After Periarticular Injection During Total Knee Arthroplasty
NCT02570503
Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis
NCT02534805
Study of Regorafenib and Sildenafil for Advanced Solid Tumors
NCT02466802
Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder
NCT02537873
Centering Pregnancy Care + Yoga for Diverse Pregnant Women
NCT02873481
Violence Prevention Study for Youth Age 10-15
NCT02393092
Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder
NCT03143543
Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation
NCT02342795
African American Cancer Clinical Trial Decisions: Testing Tailored Messages
NCT02356549
Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis
NCT02129803
Project UPLIFT to Reduce Anxiety and Depression in CF Patients
NCT03139266
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 65 |
| Phase 3 | 13 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the Virginia Commonwealth University pipeline
77 recruiting of 558 indexed (14% open); 380 completed (68%).
Phase mix: 35 late (III/IV) vs 145 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Virginia Commonwealth University: open-pipeline peers nationwide
Peers matched on 558 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 558 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Ohio State University · 552 trials · 21% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Lindenwood University · 14% recruiting · 29 trials
- BeiGene · 14% recruiting · 65 trials
- Reproductive Medicine Associates of New Jersey · 14% recruiting · 51 trials
- University of Cincinnati · 14% recruiting · 245 trials
Related
What to do with this Virginia Commonwealth University page
558 registered trials is a research-attention snapshot, not an endorsement of Virginia Commonwealth University or any single study.
- 77 of Virginia Commonwealth University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Virginia Commonwealth University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Virginia Commonwealth University pipeline card: 558 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.